BCL10 anticorps (C-Term)
Aperçu rapide pour BCL10 anticorps (C-Term) (ABIN2209042)
Antigène
Voir toutes BCL10 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- EMFLPLRSRT VSRQC
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Bcl 10 (B Cell Leukemia 10, CIPER, mE10, CARMEN, CLAP)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- C-terminal sequence [EMFLPLRSRTVSRQC] of Bcl10.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.01 % sodium azide before the addition of 40 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C (-20°C Glycerol)
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Autre désignation
- Bcl 10
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins
Antigène
-